Current Report Filing (8-k)

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of report (Date of earliest event reported): April 5, 2017

ADVAXIS, INC.

(Exact Name of Registrant as Specified in Charter)

Delaware

(State or Other Jurisdiction

of Incorporation)

000-28489

(Commission

File Number)

02-0563870

(IRS Employer

Identification No.)

305 College Road East

Princeton, New Jersey, 08540

(Address of Principal Executive Offices)

(609) 452-9813

(Registrant’s telephone number, including area code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

[ ]	Written communications pursuant to Rule 425 under the Securities Act.
[ ]	Soliciting material pursuant to Rule 14a-12 under the Exchange Act.
[ ]	Pre-commencement communications pursuant to Rule 14d-2b under the Exchange Act.
[ ]	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.

Item 5.07. Submission of Matters to a Vote of Security Holders.

The 2017 annual meeting of stockholders of Advaxis was held on April 5, 2017. The following matters were voted on by the stockholders: the election of directors, the approval of an amendment to Advaxis’ 2015 Incentive Plan to authorize an additional 1,500,000 shares thereunder and to include a provision for pre-defined annual increases in the number of shares available for issuance, the ratification of 2015 stock option grants under Advaxis’ 2015 Incentive Plan to certain directors and officers, and the ratification of the appointment of Marcum LLP as Advaxis’ independent registered public accounting firm for the fiscal year ending October 31, 2017. At the meeting, Dr. David Sidransky, Dr. James P. Patton, Daniel J. O’Connor, Roni A. Appel, Richard J. Berman, Dr. Samir N. Khleif, Dr. Thomas J. McKearn, and Thomas J. Ridge were re-elected to the Board.

Proposal 1

The vote with respect to each nominee is set forth below:

Nominee	Total Votes For		Total Votes Withheld		Broker Non-Votes
Dr. David Sidransky		12,324,390		6,540,383		14,532,686
Dr. James P. Patton		12,589,076		6,275,697		14,532,686
Daniel J. O’Connor		18,263,858		600,915		14,532,686
Roni A. Appel		18,358,386		506,387		14,532,686
Richard J. Berman		18,339,699		525,074		14,532,686
Dr. Samir Khleif		12,761,138		6,103,635		14,532,686
Dr. Thomas J. McKearn		12,709,321		6,155,452		14,532,686
Thomas J. Ridge		18,378,020		486,753		14,532,686

Proposal 2

The vote with respect to the approval of an amendment to Advaxis’ 2015 Incentive Plan is set forth below:

Total Votes For				Total Votes Against				Abstentions				Broker Non-Votes
	10,328,658				8,407,892				128,223				14,532,686

Proposal 3

The vote with respect to the ratification of 2015 stock option grants under Advaxis’ 2015 Incentive Plan is set forth below:

Total Votes For				Total Votes Against				Abstentions				Broker Non-Votes
	10,644,448				8,045,834				174,491				14,532,686

Proposal 4

The vote with respect to the ratification of the appointment of Marcum LLP as Advaxis’ independent registered public accounting firm for the fiscal year ending October 31, 2017, is set forth below:

Total Votes For				Total Votes Against				Abstentions
	32,496,795				636,064				264,600

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.